BR112012008464A2 - processo para a fabricação de acido 2 -3 5 difluoro 3 1,1 metoxi 1,1 bifenil 4 il,amino nicotinico e composto - Google Patents
processo para a fabricação de acido 2 -3 5 difluoro 3 1,1 metoxi 1,1 bifenil 4 il,amino nicotinico e compostoInfo
- Publication number
- BR112012008464A2 BR112012008464A2 BR112012008464A BR112012008464A BR112012008464A2 BR 112012008464 A2 BR112012008464 A2 BR 112012008464A2 BR 112012008464 A BR112012008464 A BR 112012008464A BR 112012008464 A BR112012008464 A BR 112012008464A BR 112012008464 A2 BR112012008464 A2 BR 112012008464A2
- Authority
- BR
- Brazil
- Prior art keywords
- nicotinic
- difluoro
- biphenyl
- methoxy
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/803—Processes of preparation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP093822120 | 2009-10-16 | ||
| EP09382212A EP2314577A1 (en) | 2009-10-16 | 2009-10-16 | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid |
| PCT/EP2010/006283 WO2011045059A1 (en) | 2009-10-16 | 2010-10-14 | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112012008464A2 true BR112012008464A2 (pt) | 2015-09-22 |
| BR112012008464B1 BR112012008464B1 (pt) | 2021-08-24 |
Family
ID=41402565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012008464-0A BR112012008464B1 (pt) | 2009-10-16 | 2010-10-14 | Processo para a fabricação de ácido 2-[(3,5-difluoro-3-metóxi-1,1-bifenil-4-il)amino] nicotínico e composto |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US8598363B2 (pt) |
| EP (2) | EP2314577A1 (pt) |
| JP (1) | JP5809630B2 (pt) |
| KR (1) | KR101699999B1 (pt) |
| CN (2) | CN103936668A (pt) |
| AU (1) | AU2010306098B2 (pt) |
| BR (1) | BR112012008464B1 (pt) |
| CA (1) | CA2776328C (pt) |
| CL (1) | CL2012000739A1 (pt) |
| CO (1) | CO6430508A2 (pt) |
| CR (1) | CR20120185A (pt) |
| CY (1) | CY1115161T1 (pt) |
| DK (1) | DK2488497T3 (pt) |
| EA (1) | EA022805B1 (pt) |
| ES (1) | ES2467165T3 (pt) |
| HK (1) | HK1168101A1 (pt) |
| HR (1) | HRP20140523T1 (pt) |
| IL (1) | IL218446A (pt) |
| IN (1) | IN2012DN01938A (pt) |
| ME (1) | ME01812B (pt) |
| MX (1) | MX2012004033A (pt) |
| MY (1) | MY160308A (pt) |
| NZ (1) | NZ598429A (pt) |
| PE (1) | PE20121173A1 (pt) |
| PL (1) | PL2488497T3 (pt) |
| PT (1) | PT2488497E (pt) |
| RS (1) | RS53319B (pt) |
| SI (1) | SI2488497T1 (pt) |
| SM (1) | SMT201400064B (pt) |
| UA (1) | UA107811C2 (pt) |
| WO (1) | WO2011045059A1 (pt) |
| ZA (1) | ZA201201563B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2319596B1 (es) | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
| UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
| EP2135610A1 (en) * | 2008-06-20 | 2009-12-23 | Laboratorios Almirall, S.A. | Combination comprising DHODH inhibitors and methotrexate |
| EP2239256A1 (en) | 2009-03-13 | 2010-10-13 | Almirall, S.A. | Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor |
| JP7343373B2 (ja) * | 2019-12-02 | 2023-09-12 | 花王株式会社 | 香料組成物 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0837710T3 (da) | 1995-06-21 | 2002-04-02 | Sofotec Gmbh & Co Kg | Lægemiddelpulverpatron med integreret doseringsindretning og inhalator for lægemidler på pulverform |
| DE19547648A1 (de) | 1995-12-20 | 1997-06-26 | Hoechst Ag | Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate |
| DE19610955A1 (de) | 1996-03-20 | 1997-09-25 | Hoechst Ag | Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid |
| GB9804343D0 (en) | 1998-02-27 | 1998-04-22 | Univ Cardiff | Chemical compounds |
| AP2002002387A0 (en) | 1999-06-10 | 2002-03-31 | Warner Lambert Co | Method of inhibiting amyloid aggregation and imaging amyloid deposits. |
| EP1935416A3 (en) | 2001-04-05 | 2008-10-22 | Aventis Pharma Inc | (Z) -2-cyano-3-hydroxybut-2-enoic acid (4'-trifluoromethylphenyl) amide for the treatment of multiple sclerosis |
| WO2002102374A1 (en) | 2001-06-19 | 2002-12-27 | Merck & Co., Inc. | Amine salt of an integrin receptor antagonist |
| DE10129703A1 (de) | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren |
| WO2003006424A1 (en) | 2001-07-10 | 2003-01-23 | 4Sc Ag | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| DE10202940A1 (de) | 2002-01-24 | 2003-07-31 | Sofotec Gmbh & Co Kg | Patrone für einen Pulverinhalator |
| US7258118B2 (en) | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
| EP1474399A1 (en) * | 2002-02-13 | 2004-11-10 | Glaxo Group Limited | Benzenesulfonamide derivatives as antipsychotic agents |
| WO2003089414A1 (en) * | 2002-04-13 | 2003-10-30 | Hanlim Pharmaceutical Co., Ltd. | Amlodipine nicotinate and process for the preparation thereof |
| PE20040844A1 (es) * | 2002-11-26 | 2004-12-30 | Novartis Ag | Acidos fenilaceticos y derivados como inhibidores de la cox-2 |
| WO2004056747A1 (en) | 2002-12-23 | 2004-07-08 | 4Sc Ag | Dhodh-inhibitors and method for their identification |
| WO2004056746A1 (en) | 2002-12-23 | 2004-07-08 | 4Sc Ag | Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| SE0400234D0 (sv) | 2004-02-06 | 2004-02-06 | Active Biotech Ab | New compounds, methods for their preparation and use thereof |
| CA2567602A1 (en) | 2004-05-21 | 2006-01-05 | The Uab Research Foundation | Compositions and methods relating to pyrimidine synthesis inhibitors |
| WO2006022442A1 (ja) | 2004-08-24 | 2006-03-02 | Santen Pharmaceutical Co., Ltd. | ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体 |
| SG142305A1 (en) | 2004-10-19 | 2008-05-28 | Aventis Pharma Inc | Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'- trifluoromethylphenyl)-amide for treating inflammatory bowel disease |
| ES2265276B1 (es) | 2005-05-20 | 2008-02-01 | Laboratorios Almirall S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico. |
| CN1696100B (zh) * | 2005-06-01 | 2010-11-24 | 黑龙江福和华星制药集团股份有限公司 | 痤疮治疗药阿达帕林的新型简捷合成方法 |
| ES2319596B1 (es) * | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
| EP2118051B1 (en) | 2007-02-06 | 2011-05-04 | Chelsea Therapeutics, Inc. | New compounds, methods for their preparation and use thereof |
| UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
| EP2135610A1 (en) | 2008-06-20 | 2009-12-23 | Laboratorios Almirall, S.A. | Combination comprising DHODH inhibitors and methotrexate |
| EP2210615A1 (en) | 2009-01-21 | 2010-07-28 | Almirall, S.A. | Combinations comprising methotrexate and DHODH inhibitors |
| EP2228367A1 (en) | 2009-03-13 | 2010-09-15 | Almirall, S.A. | Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors |
| EP2230232A1 (en) | 2009-03-13 | 2010-09-22 | Almirall, S.A. | Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors |
| EP2239256A1 (en) | 2009-03-13 | 2010-10-13 | Almirall, S.A. | Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor |
-
2009
- 2009-10-16 EP EP09382212A patent/EP2314577A1/en not_active Withdrawn
-
2010
- 2010-10-14 SI SI201030632T patent/SI2488497T1/sl unknown
- 2010-10-14 ES ES10765586.2T patent/ES2467165T3/es active Active
- 2010-10-14 RS RS20140253A patent/RS53319B/en unknown
- 2010-10-14 PT PT107655862T patent/PT2488497E/pt unknown
- 2010-10-14 DK DK10765586.2T patent/DK2488497T3/da active
- 2010-10-14 PE PE2012000491A patent/PE20121173A1/es active IP Right Grant
- 2010-10-14 CN CN201410085756.0A patent/CN103936668A/zh active Pending
- 2010-10-14 WO PCT/EP2010/006283 patent/WO2011045059A1/en active Application Filing
- 2010-10-14 PL PL10765586T patent/PL2488497T3/pl unknown
- 2010-10-14 MY MYPI2012001685A patent/MY160308A/en unknown
- 2010-10-14 EA EA201200594A patent/EA022805B1/ru unknown
- 2010-10-14 BR BR112012008464-0A patent/BR112012008464B1/pt active IP Right Grant
- 2010-10-14 NZ NZ598429A patent/NZ598429A/en unknown
- 2010-10-14 JP JP2012533527A patent/JP5809630B2/ja active Active
- 2010-10-14 EP EP10765586.2A patent/EP2488497B1/en active Active
- 2010-10-14 MX MX2012004033A patent/MX2012004033A/es active IP Right Grant
- 2010-10-14 KR KR1020127009609A patent/KR101699999B1/ko active IP Right Grant
- 2010-10-14 CA CA2776328A patent/CA2776328C/en active Active
- 2010-10-14 AU AU2010306098A patent/AU2010306098B2/en active Active
- 2010-10-14 UA UAA201205649A patent/UA107811C2/ru unknown
- 2010-10-14 CN CN201080046816.8A patent/CN102574800B/zh active Active
- 2010-10-14 US US13/501,847 patent/US8598363B2/en active Active
- 2010-10-14 ME MEP-2014-50A patent/ME01812B/me unknown
-
2012
- 2012-03-01 IL IL218446A patent/IL218446A/en active IP Right Grant
- 2012-03-01 ZA ZA2012/01563A patent/ZA201201563B/en unknown
- 2012-03-05 IN IN1938DEN2012 patent/IN2012DN01938A/en unknown
- 2012-03-23 CL CL2012000739A patent/CL2012000739A1/es unknown
- 2012-04-16 CR CR20120185A patent/CR20120185A/es unknown
- 2012-04-16 CO CO12061780A patent/CO6430508A2/es active IP Right Grant
- 2012-09-12 HK HK12108881.1A patent/HK1168101A1/xx unknown
-
2014
- 2014-06-03 SM SM201400064T patent/SMT201400064B/xx unknown
- 2014-06-05 HR HRP20140523AT patent/HRP20140523T1/hr unknown
- 2014-06-06 CY CY20141100405T patent/CY1115161T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1015062A2 (pt) | "processo para preparar ácido fórmico" | |
| BRPI0910910A2 (pt) | processo para preparar um composto | |
| BRPI0910911A2 (pt) | processo para preparar um composto | |
| BRPI0815825A2 (pt) | Processo para a produção de um óxido de olefina | |
| BRPI0816478A2 (pt) | Processo para produção de celulases | |
| BR112013017767A2 (pt) | processo de injeção multi-estácio para produção de recurso aperfeiçoada a partir de xisto | |
| IT1401911B1 (it) | Processo per la sintesi di acido 2,5-furandicarbossilico | |
| BRPI0812304A2 (pt) | Processo para a produção de p4o6 | |
| BRPI0810067A2 (pt) | Processo para a preparação de capecitabina | |
| BRPI0811644A2 (pt) | Processo para a produção de pirazóis | |
| BRPI1010128A2 (pt) | "processo para a fabricação do 2,3,3,3 - tetrafluropropeno" | |
| BRPI1014812A2 (pt) | Processo para a produção de alacoóis | |
| BR112012000209A2 (pt) | processo para a produção de heterodímeros de ácido glutâmico | |
| BRPI0913217A2 (pt) | processo para a produção de etileno | |
| BR112012001937A2 (pt) | método para a produção de 2,2-difluoroetilamina | |
| EP2411398A4 (en) | PROCESS FOR THE PRODUCTION OF ESTER COMPOUND OF BORONIC ACID | |
| BRPI0810216A2 (pt) | Processo para a preparação de composto, composto, e, método de tratamento de distúrbio bipolar | |
| BRPI0817747A2 (pt) | Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico | |
| BRPI0813960A2 (pt) | Processo para produção de biarilas | |
| BRPI0921736A2 (pt) | processo para a fabricação de p4o6 com alto rendimento | |
| FR2975990B1 (fr) | Procede de preparation d'un compose organique fluore | |
| BR112012008464A2 (pt) | processo para a fabricação de acido 2 -3 5 difluoro 3 1,1 metoxi 1,1 bifenil 4 il,amino nicotinico e composto | |
| BRPI0908900A2 (pt) | processo para a produção de polióis | |
| BRPI1011671A2 (pt) | processo para produzir cristais de forma a de ácido 2-(3-ciano-4-isobutiloxifenil)-4metil-5-tiazolacarbocíclico | |
| BRPI0922219A2 (pt) | processo para a produção de vacinas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07D 213/80 , C07D 213/803 , C07C 211/45 , C07C 211/64 Ipc: C07D 213/80 (2006.01), C07D 213/803 (2006.01), C07 |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/10/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |